You are here
Gilead cash pile burns hole in investors' pockets
IN THE drug industry's biggest-ever period for deals, one wildly successful company with a multibillion-dollar war chest has been oddly silent. So what's Gilead Sciences Inc waiting for?
Drugmakers have done US$179 billion worth of mergers and acquisitions so far this
CALL +65 6388 3838 EMAIL firstname.lastname@example.org